The ventral striatopallidal parts of the basal ganglia in the rat—II. Compartmentation of ventral pallidal efferents

doi:10.1016/0306-4522(89)90351-5

Neuroscience

Volume 30, Issue 1, 1989, Pages 33-50

https://doi.org/10.1016/0306-4522(89)90351-5 Get rights and content

Abstract

This paper describes the results of experiments designed to address whether neuron populations giving rise to different ventral pallidal efferent projections are segregated in a manner concordant with the recently described immunohistochemical compartmentation of ventral pallidum. The retrograde transport of horseradish peroxidase conjugated to wheatgerm agglutinin following injections in the ventral tegmental area of Tsai, medial substantia nigra and subthalamic nucleus was charted in relationship to the patterns of immunohistochemical staining in the forebrain following incubation of sections in antisera against substance P, neurotensin or leucine-enkephalin. In some cases the retrograde labeling and immunohistochemical protocols were combined in the same experiment. As a supplement, the electron microscope was utilized to investigate the ultrastructure and synaptic input of projecting cells making up populations of ventral pallidum neurons that project to different efferent targets. The results indicated that the immunocytochemical compartmentation of ventral pallidum observed in our earlier study is reflected in the organization of neurons from which ventral pallidal efferents originate. Thus, axons destined to terminate in the medial parts of substantia nigra and subthalamic nucleus project from neurons located in the lateral, neurotensin immunoreactivity-deficient part of ventral pallidum and the globus pallidus. Fibers en route to the ventral tegmental area originate in neurotensin immunoreactivity-rich medial parts of the ventral pallidum as part of a large cluster of retrogradely labeled neurons that invades several forebrain structures, including the bed nucleus of the stria terminalis, preoptic regions, and the nuclei of the diagonal band.

The electron microscopic results provided additional evidence distinguishing the medial and lateral compartments of ventral pallidum. Whereas projection neurons located in both compartments display similar cytologic features, the density of synaptic input to retrogradely labeled perikarya and proximal dendrites following injections in the subthalamic nucleus is significantly greater than that seen following injections in the ventral tegmental area. Although no attempt was made to examine more distal parts of labeled dendrites in the present study, the observation that most dendritic profiles in the medial part of ventral pallidum were less contacted by boutons than their counterparts in the lateral district suggests that the level of innervation of projection neurons is generally lesser in medial ventral pallidum. This hypothesis is further supported by the presence in the medial ventral pallidum of significant numbers of “glial blockades,” a cytologic configuration that is clearly capable of preventing functional interactions and is rarely observed in the lateral ventral pallidum.

Our investigation has addressed whether neurons that project to the ventral tegmental area exhibit modifications of phenotype which distinguish them or are segregated from their counterparts that project to other targets. Segregation and differences in the level of innervation of neurons projecting to the ventral tegmental area were observed.

Reference (51)

AlheidG.F. et al.
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders; the striatopallidal, amygdaloid and corticopetal components of substantia innominata
Neuroscience
(1988)
BecksteadR.M. et al.
Efferent connections of the substantia nigra and ventral tegmental area in the rat
Brain Res.
(1979)
BerkM.L. et al.
Afferent projections to the preoptic area and hypothalamic regions in the rat brain
Neuroscience
(1981)
BunneyB.S. et al.
The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique
Brain Res.
(1976)
EggermanK.W. et al.
Numbers of neurotensin-immunoreactive neurons selectively increased in rat ventral striatum following acute haloperidol administration
Neuropeptides
(1988)
GrofovaI.
The identification of striatal and pallidal neurons projecting to substantia nigra. An experimental study by means of retrograde axonal transport of horseradish peroxidase
Brain Res.
(1975)
HaberS.H. et al.
Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry
Neuroscience
(1983)
HeimerL. et al.
Ventral striatum and ventral pallidum. Components of the motor system?
Trends Neurosci.
(1982)
ItayaS.K. et al.
Anterograde transsynaptic transport of WGA HRP in the limbic system of rat and monkey
Brain Res.
(1986)
MogensonG.J. et al.
Evidence that projections from substantia innominata to zona incerta and mesencephalic locomotor region contribute to locomotor activity
Brain Res.
(1985)

NautaH.J.W.

Projections of the pallidal complex: an autoradiography study in the cat

Neuroscience

(1979)

NautaW.J.H. et al.

Projections of the lentiform nucleus in the monkey

Brain Res.

(1966)

NautaW.J.H. et al.

Efferent connections and nigral afferents of the nucleus accumbens septi in the rat

Neuroscience

(1978)

OadesR.D. et al.

Ventral tegmental (A10) system: neurobiology. I. Anatomy and connectivity

Brain Res. Rev.

(1987)

Shammah-LagnadoS.J. et al.

Afferent connections of the mesencephalic reticular formation: a horseradish peroxidase study in the rat

Neuroscience

(1983)

SimonH. et al.

Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [³H]leucine and horseradish peroxidase

Brain Res.

(1979)

SwansonL.W. et al.

Evidence for a projection from the lateral preoptic area and substantia innominata to the mesencephalic locomotor region in the rat

Brain Res.

(1984)

SwansonL.W. et al.

Anatomical and electrophysiological evidence for a projection from the medial preoptic area to the mesencephalic and subthalamic locomotor regions in the rat

Brain Res.

(1987)

YangC.R. et al.

Hippocampal signal transmission to the pendunculopontine nucleus and its regulation by dopamine D₂ receptors in the nucleus accumbens: an electrophysiological and behavioral study

Neuroscience

(1987)

ZahmD.S.

Concentration of neurotensin immunoreactive neurons in the ventral striatum of the rat: ventromedial caudate-putamen, nucleus accumbens and olfactory tubercle

Neurosci. Lett.

(1987)

ZahmD.S. et al.

Evidence for the coexistence of glutamate decar☐ylase and met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum

Brain Res.

(1985)

BecksteadR.M. et al.

Immunohistochemical demonstration of differential substance P, metenkephalin, and glutamic acid-decar☐ylase containing cell body and axon distribution in the corpus striatum of the cat

J. comp. Neurol.

(1985)

CarterD.A. et al.

The projections of the entopeduncular nucleus and globus pallidus in rat as demonstrated by autoradiography and horseradish peroxidase histochemistry

J. comp. Neurol.

(1978)

FallonJ.H. et al.

Substantia nigra

GroenewegenH.J. et al.

Efferent projections of the ventral pallidum in the rat as studied with the anterograde transport of Phaseolus vulgaris-leucoagglutinin

Neurosci. Lett. Suppl.

(1984)

Cited by (187)

Pallidal circuits drive addiction behavior
2023, Trends in Neurosciences
Understanding the neural mechanisms that control addiction processes, including drug-seeking and relapse, is key to finding new targets for substance use disorder (SUD) pharmacotherapies and circuit-based therapies. Addictive drugs alter activity in distinct neural circuits that can lead to SUD symptoms, including compulsive drug craving and taking. This includes the pallidum, a region in the basal ganglia that acts as an integrator of associative, sensorimotor, and limbic information to shape motor responses, promote reward-learning, and regulate habit formation. Here, we review key findings that demonstrate the sub-regional and circuit-specific functions of the pallidum that drive addiction-related behaviors in rodents. We also highlight newly discovered mechanisms within distinct cell types and circuits of the pallidum that drive drug-seeking. Overall, this review serves to emphasize the importance of the pallidum in addiction processes and underscore the need for studying circuit-specific mechanisms in SUD research.
Striatal circuits
2022, Neurocircuitry of Addiction
The striatum is a subcortical structure that serves as the primary input nucleus of the basal ganglia. Through its diverse arrangement of afferent and efferent connections, the striatum regulates the expression of actions by integrating motor commands with cognitive, motivational, and emotional input (Haber, 2016). By merging internal value with external cues, the striatum learns which actions, and in which context, result in the acquisition of a reward and reinforces those actions to guide future reward-driven behavior. If the reward being sought is a drug of abuse, the striatum pathologically promotes actions that lead to acquisition of the substance. Consider the process of drinking a few beers after a stressful week of work. Execution of this behavior requires the selection of a motor plan motivated by an internal drive (e.g., to reduce stress) and the integration of the reward history of that motor action (e.g., drinking previously was rewarding). Once this motor program is learned, through repeated execution and reinforcement, this behavior becomes engrained in striatal circuits and can be elicited almost automatically by sensory cues in the environment—even in the face of known negative consequences (e.g., drinking previously led to poor work performance). As such, the striatum plays a fundamental role in the decisions and actions we make every day, and by extension how we define ourselves through those actions.
Ventral pallidum cellular and pathway specificity in drug seeking
2021, Neuroscience and Biobehavioral Reviews
Citation Excerpt :
This subdivision is mainly based on staining of various neuropeptides expressed mainly by incoming woolly fibers (Haber and Nauta, 1983; Zahm and Heimer, 1990). For example, the dorsolateral VP is delineated by enkephalin or calbindin-d28k staining (Zahm et al., 1996; Tripathi et al., 2010) whereas the ventromedial VP shows dense neurotensin expression (Zahm et al., 1996; Root et al., 2015) and substance P is expressed throughout the VP and neatly delineates the entire structure (Zahm, 1989; Farrell et al., 2019). The VP had also been suggested to consist of anterior and posterior subdivisions (Smith and Berridge, 2005; Smith et al., 2009).
The ventral pallidum (VP) is central to the reinforcing effects across a variety of drugs and relapse to drug seeking. Emerging studies from animal models of reinstatement reveal a complex neurobiology of the VP that contributes to different aspects of relapse to drug seeking. This review builds on classical understanding of the VP as part of the final common pathway of relapse but also discusses the properties of the VP as an independent structure. These include VP neural anatomical subregions, cellular heterogeneity, circuitry, neurotransmitters and peptides. Collectively, this review provides a current understanding of the VP from molecular to circuit level architecture that contributes to both the appetitive and aversive symptoms of drug addiction. We show the complex neurobiology of the VP in drug seeking, emphasizing its critical role in addiction, and review strategic approaches that target the VP to reduce relapse rates.
Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior
2019, Neurochemistry International
Dopamine D2 receptors (D2Rs) mediate many of the actions of dopamine in the striatum, ranging from movement to the effortful pursuit of reward. Yet despite significant advances in linking D2Rs to striatal functions with pharmacological and genetic strategies in animals, how dopamine orchestrates its myriad actions on different cell populations —each expressing D2Rs— remains unclear. Furthermore, brain imaging and genetic studies in humans have consistently associated striatal D2R alterations with various neurological and neuropsychiatric disorders, but how and which D2Rs are involved in each case is poorly understood. Therefore, a critical first step is to engage in a refined and systematic investigation of the impact of D2R function on specific striatal cells, circuits, and behaviors. Here, I will review recent efforts, primarily in animal models, aimed at unlocking the complex and heterogeneous roles of D2Rs in striatum.
Anatomy and connectivity of the reward circuit
2017, Decision Neuroscience: An Integrative Perspective
While cells in many brain regions are responsive to reward, the cortical–basal ganglia circuit is at the heart of the reward system. The key structures in this network are the anterior cingulate cortex, the orbital prefrontal cortex, the ventral striatum, the ventral pallidum, and the midbrain dopamine neurons. In addition, other structures, including the dorsal prefrontal cortex, amygdala, thalamus, and lateral habenular nucleus, are key components in regulating the reward circuit. Connectivity between these areas forms a complex neural network that is topographically organized, thus maintaining functional continuity through the corticobasal ganglia pathway. However, the reward circuit does not work in isolation. The network also contains specific regions in which convergent pathways provide an anatomical substrate for integration across functional domains.
Anxiolytic effect of neurotensin microinjection into the ventral pallidum
2015, Behavioural Brain Research
Neurotensin (NT) acts as a neurotransmitter and neuromodulator in the central nervous system. NT is involved in reward and memory processes, drug addiction and also in the regulation of anxiety. The ventral pallidum (VP) receives neurotensinergic innervation from the ventral striatopallidal pathway originating from the nucleus accumbens. Positive reinforcing effects of NT in the VP had been shown recently, however the possible effects of NT on anxiety have not been examined yet.
In our present experiments, the effects of NT on anxiety were investigated in the VP. In male Wistar rats bilateral microinjections of 100 ng or 250 ng NT were delivered in the volume of 0.4 μl into the VP, and elevated plus maze (EPM) test was performed. In another groups of animals, 35 ng NT-receptor 1 (NTR1) antagonist SR 48,692 was applied by itself, or microinjected 15 min before 100 ng NT treatment. Open field test (OPF) was also conducted.
The 100 ng dose of NT had anxiolytic effect, but the 250 ng NT did not influence anxiety. The antagonist pretreatment inhibited the effect of NT, while the antagonist itself had no effect. In the OPF test there was no difference among the groups. Our present results show that microinjection of NT into the VP induces anxiolytic effect, which is specific to the NTR1 receptors because it can be eliminated by a specific NTR1 antagonist. It is also substantiated that neither the NT, nor the NTR1 antagonist in the VP influences locomotor activity.

View all citing articles on Scopus

View full text

The ventral striatopallidal parts of the basal ganglia in the rat—II. Compartmentation of ventral pallidal efferents

Abstract

Neuroscience

Brain Res.

Neuroscience

Brain Res.

Neuropeptides

Brain Res.

Neuroscience

Trends Neurosci.

Brain Res.

Brain Res.

Neuroscience

Brain Res.

Neuroscience

Brain Res. Rev.

Neuroscience

Brain Res.

Brain Res.

Brain Res.

Neuroscience

Neurosci. Lett.

Brain Res.

Immunohistochemical demonstration of differential substance P, metenkephalin, and glutamic acid-decar☐ylase containing cell body and axon distribution in the corpus striatum of the cat

J. comp. Neurol.

The projections of the entopeduncular nucleus and globus pallidus in rat as demonstrated by autoradiography and horseradish peroxidase histochemistry

J. comp. Neurol.

Substantia nigra

Efferent projections of the ventral pallidum in the rat as studied with the anterograde transport of Phaseolus vulgaris-leucoagglutinin

Neurosci. Lett. Suppl.